Effects of wogonoside on invasion and migration of lung cancer A549 cells and angiogenesis in xenograft tumors of nude mice

被引:16
作者
Yan, Yubo [1 ]
Yao, Lei [1 ]
Sun, Haobo [1 ]
Pang, Sainan [1 ]
Kong, Xianglong [1 ]
Zhao, Su [1 ]
Xu, Shidong [1 ]
机构
[1] Harbin Med Univ, Affiliated Canc Hosp, Dept Thorac Surg, Harbin 150000, Peoples R China
关键词
Wogonoside; lung cancer; invasion; migration; angiogenesis; EPITHELIAL-MESENCHYMAL TRANSITION; CYCLE ARREST; LEUKEMIA;
D O I
10.21037/jtd-20-1555
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Lung cancer is the most prevalent and deadly tumors around the world. Here we aimed to investigate the effect of wogonoside (also called baicalin) on the invasion and migration of lung cancer A549 cells and angiogenesis in xenograft tumors in nude mice. Methods: A549 cells of lung cancer were treated with different doses of wogonoside. After 24 h, CCK8 was used to detect the survival rate of cells. The non-toxic doses of wogonoside (0, 10, 25, and 50 mu M) were selected for subsequent experiments. Transwell and scratch assays were used to detect invasion and migration. The number of microtubule nodules was detected by microtubule formation experiment, and the expressions of VEGF, E-cadherin, N-cadherin, and Vimentin were detected by Western blotting. BALB/c nude mice were subcutaneously injected with lung cancer A549 cells to establish the xenograft model, followed by intraperitoneal injection of 80 mg/kg of wogonoside. After 30 days, tumor volume was measured, and the levels of VEGF and vimentin were detected with immunohistochemistry. The level of CD34 was determined by flow sorting. Results: A549 cell survival decreased in a concentration-dependent manner, with the survival rate significantly reduced when the concentration of wogonoside exceeded 100 mu M (P<0.05). A549 cell invasion and the number of microtubule nodules were significantly lower in the wogonoside 20 mu M and the wogonoside 50 mu M groups (P<0.05) compared with the wogonoside 0 mu M group, while the rate of scratch closure and the protein levels of VEGF, N-cadherin, and Vimentin were all significantly reduced (P<0.05), and the expression level of E-cadherin was significantly increased (P<0.05). Compared with the control group, the tumor volumes of wogonoside (80 mg/kg) treated mice were significantly reduced after 30 days (P<0.05), and the levels of VEGF and vimentin positive cells were significantly reduced (P<0.05), as was the level of CD34 (P<0.05). Conclusions: Wogonoside can inhibit the invasion and migration of lung cancer A549 cells and angiogenesis of xenograft tumors in nude mice.
引用
收藏
页码:1552 / 1560
页数:9
相关论文
共 21 条
[1]   Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases [J].
Fallah, Asghar ;
Sadeghinia, Ali ;
Kahroba, Houman ;
Samadi, Amin ;
Heidari, Hamid Reza ;
Bradaran, Behzad ;
Zeinali, Sirous ;
Molavi, Ommoleila .
BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 :775-785
[2]   Tumour-cell invasion and migration: Diversity and escape mechanisms [J].
Friedl, P ;
Wolf, K .
NATURE REVIEWS CANCER, 2003, 3 (05) :362-374
[3]   Wogonoside inhibits cell growth and induces mitochondrial-mediated autophagy-related apoptosis in human colon cancer cells through the PI3K/AKT/mTOR/p70S6K signaling pathway [J].
Han, Chengzheng ;
Xing, Guozheng ;
Zhang, Mengying ;
Zhong, Min ;
Han, Zhen ;
He, Chiyi ;
Liu, Xiaoping .
ONCOLOGY LETTERS, 2018, 15 (04) :4463-4470
[4]   A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling [J].
Huang, Yujie ;
Fang, Jiansong ;
Lu, Weiqiang ;
Wang, Zihao ;
Wang, Qi ;
Hou, Yuan ;
Jiang, Xingwu ;
Reizes, Ofer ;
Lathia, Justin ;
Nussinov, Ruth ;
Eng, Charis ;
Cheng, Feixiong .
CELL CHEMICAL BIOLOGY, 2019, 26 (08) :1143-+
[5]   Wogonoside Inhibits Angiogenesis in Breast Cancer Via Suppressing Wnt/β-Catenin Pathway [J].
Huang, Yujie ;
Zhao, Kai ;
Hu, Yang ;
Zhou, Yuxin ;
Luo, Xuwei ;
Li, Xiaorui ;
Wei, Libin ;
Li, Zhiyu ;
You, Qidong ;
Guo, Qinglong ;
Lu, Na .
MOLECULAR CARCINOGENESIS, 2016, 55 (11) :1598-1612
[6]   Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined [J].
Le, Xiuning ;
Hanna, Ehab Y. .
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
[7]   Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells [J].
Li, Hui ;
Hui, Hui ;
Xu, Jingyan ;
Yang, Hao ;
Zhang, Xiaoxiao ;
Liu, Xiao ;
Zhou, Yuxin ;
Li, Zhiyu ;
Guo, Qinglong ;
Lu, Na .
ARCHIVES OF TOXICOLOGY, 2016, 90 (06) :1507-1522
[8]   Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis [J].
Lin, Binyan ;
Zhao, Kai ;
Yang, Dawei ;
Bai, Dongsheng ;
Liao, Yan ;
Zhou, Yuxin ;
Yu, Zhou ;
Yu, Xiaoxuan ;
Guo, Qinglong ;
Lu, Na .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (02) :1913-1924
[9]   Epithelial Mesenchymal Transition in Tumor Metastasis [J].
Mittal, Vivek .
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13, 2018, 13 :395-412
[10]   Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer [J].
Odero-Marah, Valerie ;
Hawsawi, Ohuod ;
Henderson, Veronica ;
Sweeney, Janae .
CELL & MOLECULAR BIOLOGY OF PROSTATE CANCER: UPDATES, INSIGHTS AND NEW FRONTIERS, 2018, 1095 :101-110